AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
AUTOLOGOUS CD34-SELECTED BLOOD PROGENITOR-CELL TRANSPLANTS FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA
Authors: SCHILLER G VESCIO R FREYTES C SPITZER G LEE M WU CH CAO J LEE JC LICHTENSTEIN A LILL M BERENSON R BERENSON J
Citation: G. Schiller et al., AUTOLOGOUS CD34-SELECTED BLOOD PROGENITOR-CELL TRANSPLANTS FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA, Bone marrow transplantation, 21(2), 1998, pp. 141-145
BCL-X EXPRESSION IN MULTIPLE-MYELOMA - POSSIBLE INDICATOR OF CHEMORESISTANCE
Authors: TU YP RENNER S XU FH FLEISHMAN A TAYLOR J WEISZ J VESCIO R RETTIG M BERENSON J KRAJEWSKI S REED JC LICHTENSTEIN A
Citation: Yp. Tu et al., BCL-X EXPRESSION IN MULTIPLE-MYELOMA - POSSIBLE INDICATOR OF CHEMORESISTANCE, Cancer research, 58(2), 1998, pp. 256-262
PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN PATIENTS WITH CANCER WITHNORMAL OR IMPAIRED RENAL-FUNCTION
Authors: BERENSON JR ROSEN L VESCIO R LAU HS WOO M SIOUFI A KOWALSKI O KNIGHT RD SEAMAN JJ
Citation: Jr. Berenson et al., PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN PATIENTS WITH CANCER WITHNORMAL OR IMPAIRED RENAL-FUNCTION, Journal of clinical pharmacology, 37(4), 1997, pp. 285-290
THE PHARMACOKINETICS OF PAMIDRONATE DISODIUM(P) IN CANCER-PATIENTS WITH NORMAL OR IMPAIRED RENAL-FUNCTION
Authors: SEAMAN J BERENSON J ROSEN L VESCIO R LAU H WOO M SIOUFI A KOWALSKI MO KNIGHT R
Citation: J. Seaman et al., THE PHARMACOKINETICS OF PAMIDRONATE DISODIUM(P) IN CANCER-PATIENTS WITH NORMAL OR IMPAIRED RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 94-94
ANALYSIS OF THE P16(INK4A), P15(INK4B) AND P18(INK4C) GENES IN MULTIPLE-MYELOMA
Authors: TASAKA T BERENSON J VESCIO R HIRAMA T MILLER CW NAGAI M TAKAHARA J KOEFFLER HP
Citation: T. Tasaka et al., ANALYSIS OF THE P16(INK4A), P15(INK4B) AND P18(INK4C) GENES IN MULTIPLE-MYELOMA, British Journal of Haematology, 96(1), 1997, pp. 98-102
DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS IN THE DENDRITIC CELLS OF WALDENSTROMS MACROGLOBULINEMIA AND PRIMARY AMYLOIDOSIS PATIENTS
Authors: RETTIG M VESCIO R MA H MOSS T SCHILLER G SAID J BERENSON J
Citation: M. Rettig et al., DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS IN THE DENDRITIC CELLS OF WALDENSTROMS MACROGLOBULINEMIA AND PRIMARY AMYLOIDOSIS PATIENTS, Blood, 90(10), 1997, pp. 374-374
SEQUENCE VARIABILITY OF HHV-8 FROM THE DENDRITIC CELLS OF MULTIPLE-MYELOMA PATIENTS
Authors: RETTIG M VESCIO R MA H SCHILLER G SAVAGE A BERENSON J
Citation: M. Rettig et al., SEQUENCE VARIABILITY OF HHV-8 FROM THE DENDRITIC CELLS OF MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 376-376
BCL-2 BAX EXPRESSION IN PLASMA-CELL DYSCRASIAS/
Authors: RENNER S WEISZ J FLEISHMAN A TAYLOR J VESCIO R RETTIG M BERENSON J KRAJEWSKI S REED JC LICHTENSTEIN A
Citation: S. Renner et al., BCL-2 BAX EXPRESSION IN PLASMA-CELL DYSCRASIAS/, Blood, 90(10), 1997, pp. 401-401
A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL)
Authors: SCHILLER G STEWART AK BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANFOLO S STIFF P PINEIRO L DALTON W HO A VESCIO R BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: G. Schiller et al., A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 960-960
EXPRESSION OF NOVEL GENES IN HUMAN CHROMOSOMAL LOCUS 11Q13
Authors: POLD M RETTIG M MUNROE D VESCIO R HALL J BERENSON J
Citation: M. Pold et al., EXPRESSION OF NOVEL GENES IN HUMAN CHROMOSOMAL LOCUS 11Q13, Blood, 90(10), 1997, pp. 1413-1413
FUNCTIONAL DEFICITS IN BONE-MARROW-DERIVED DENDRITIC TELLS INFECTED WITH KSHV IN MULTIPLE-MYELOMA PATIENTS
Authors: NEPOM GT MASEWICZ S RETTIG M BELSON D VESCIO R BERENSON J
Citation: Gt. Nepom et al., FUNCTIONAL DEFICITS IN BONE-MARROW-DERIVED DENDRITIC TELLS INFECTED WITH KSHV IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 1575-1575
MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE, Blood, 90(10), 1997, pp. 1872-1872
INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2515-2515
THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION
Authors: VESCIO R WU C RETTIG M STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION, Blood, 90(10), 1997, pp. 2516-2516
DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS IN THE PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS
Authors: RETTIG M VESCIO R MOSS T MA H SCHILLER G BERENSON J
Citation: M. Rettig et al., DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS IN THE PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2611-2611
BONE-MARROW BIOPSIES FROM BONE MULTIPLE-MYELOMA PATIENTS CONTAIN KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS
Authors: BERENSON J RETTIG M HEPPNER K VESCIO R MA H SCHILLER G BELSON D SAVAGE A NISHIKUBO C SHINTAKU I KOEFFLER H ASOU H PINKUS G SCHRAGE M GREEN E SAID J
Citation: J. Berenson et al., BONE-MARROW BIOPSIES FROM BONE MULTIPLE-MYELOMA PATIENTS CONTAIN KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS, Blood, 90(10), 1997, pp. 2612-2612
UP-REGULATED EXPRESSION OF BCL-2 IN MULTIPLE-MYELOMA CELLS INDUCED BYEXPOSURE TO DOXORUBICIN, ETOPOSIDE, AND HYDROGEN-PEROXIDE
Authors: TU YP XU FH LIU J VESCIO R BERENSON J FADY C LICHTENSTEIN A
Citation: Yp. Tu et al., UP-REGULATED EXPRESSION OF BCL-2 IN MULTIPLE-MYELOMA CELLS INDUCED BYEXPOSURE TO DOXORUBICIN, ETOPOSIDE, AND HYDROGEN-PEROXIDE, Blood, 88(5), 1996, pp. 1805-1812
LONG-TERM OUTCOME OF A PHASE-II STUDY OF AUTOLOGOUS CD34-BLOOD STEM-CELL TRANSPLANTATION AS TREATMENT FOR MULTIPLE-MYELOMA( PERIPHERAL)
Authors: SCHILLER G VESCIO R LEE M SPITZER G FREYTES C LILL M BERENSON R BERENSON I
Citation: G. Schiller et al., LONG-TERM OUTCOME OF A PHASE-II STUDY OF AUTOLOGOUS CD34-BLOOD STEM-CELL TRANSPLANTATION AS TREATMENT FOR MULTIPLE-MYELOMA( PERIPHERAL), Blood, 88(10), 1996, pp. 1919-1919
TRANSPLANTATION OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS FOLLOWING HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA
Authors: BERENSON J SCHILLER G VESCIO R FREYTES C SPITZER G LEE M LICHTENSTEIN A LILL M HALL J BERENSON R
Citation: J. Berenson et al., TRANSPLANTATION OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS FOLLOWING HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA, Journal of cellular biochemistry, 1995, pp. 361-361
INTERLEUKIN-6 INHIBITS APOPTOSIS OF MALIGNANT PLASMA-CELLS
Authors: LICHTENSTEIN A TU YP FADY C VESCIO R BERENSON J
Citation: A. Lichtenstein et al., INTERLEUKIN-6 INHIBITS APOPTOSIS OF MALIGNANT PLASMA-CELLS, Cellular immunology, 162(2), 1995, pp. 248-255
INTERLEUKIN-6 PROTECTION AGAINST MULTIPLE-MYELOMA PLASMA-CELLS - ROLEOF CELL-CYCLE ALTERATIONS, BCL-FAMILY OF PROTEINS AND PROTEIN-TYROSINE KINASES
Authors: XU F TU Y LIU J VESCIO R BERENSON J LICHTENSTEIN A
Citation: F. Xu et al., INTERLEUKIN-6 PROTECTION AGAINST MULTIPLE-MYELOMA PLASMA-CELLS - ROLEOF CELL-CYCLE ALTERATIONS, BCL-FAMILY OF PROTEINS AND PROTEIN-TYROSINE KINASES, Blood, 86(10), 1995, pp. 233-233
EXPRESSION OF BCL-X IN MULTIPLE-MYELOMA PLASMA-CELLS
Authors: TU Y XU F LIU J VESCIO R BERENSON J KRAJEWSKI S REED J LICHTENSTEIN A
Citation: Y. Tu et al., EXPRESSION OF BCL-X IN MULTIPLE-MYELOMA PLASMA-CELLS, Blood, 86(10), 1995, pp. 234-234
INFECTIOUS COMPLICATIONS IN MULTIPLE-MYELOMA
Authors: LIGHTNER A ROSEN L VESCIO R SCHILLER G BERENSON J
Citation: A. Lightner et al., INFECTIOUS COMPLICATIONS IN MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 741-741
A PHASE I-II STUDY OF INFUSIONAL IDARUBICIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE FOR THE TREATMENT OF RESISTANT MULTIPLE-MYELOMA
Authors: SCHILLER G VESCIO R MITTALHENKLE A ROSEN L BEESEMYER R BERENSON J
Citation: G. Schiller et al., A PHASE I-II STUDY OF INFUSIONAL IDARUBICIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE FOR THE TREATMENT OF RESISTANT MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 3355-3355
TRANSPLANTATION OF CD34(-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA() PERIPHERAL)
Authors: SCHILLER G VESCIO R FREYTES C SPITZER G SAHEBI F LEE M WU CH CAO J LEE JC HONG CH LICHTENSTEIN A LILL M HALL J BERENSON R BERENSON J
Citation: G. Schiller et al., TRANSPLANTATION OF CD34(-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA() PERIPHERAL), Blood, 86(1), 1995, pp. 390-397
Risultati: 1-25 | 26-36